AB103
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for AB103, covering 2021-04-27 to 2021-10-05. Get the full timeline:
Most recent: Clinical Trial Update: Phase III Efficacy and Safety Study of AB103 in the Treatment of Patients With Necrotizing Soft Tissue Infections [Phase 3]